My guest this week is Dr. Adel Zarei. Dr. Zarei earned his Ph.D. degree from Leiden University in the Netherlands, specializing in molecular mechanisms governing defense and secondary metabolism in plants. Dr. Zarei spent a decade as a Research Associate at the University of Guelph, where his research focused on stress physiology in plants. His primary passion lies in the study of plant secondary metabolites, many of which possess pharmaceutical significance. In 2017, Adel transitioned to the Cannabis industry, serving as a Scientific Advisor and Cannabis Micropropagation Expert. He played a pivotal role in designing and establishing multiple Cannabis Micropropagation labs for Cannabis Production License Holders. His groundbreaking work in this field garnered multiple Government grants and led to the development of commercial-scale cannabis micropropagation techniques. The results of this research were published in prestigious peer-reviewed journals, including In Vitro Cellular and Developmental Biology-Plant and Plants”. Throughout his scientific career, Adel has authored more than twenty-two peer-reviewed articles covering topics such as plant stress physiology, secondary metabolites, and plant pathology.

Dr. Zarei is an integral member of the PharmaCrop team, serving as the Chief Operating Officer at PharmaCrop Pty. Ltd. in Queensland, Australia. In this role, he oversees operations that encompass every stage of the process, from seed cultivation to the final production of medical-grade cannabis products. Dr. Zarei has successfully transferred his extensive knowledge and experience in the cultivation and processing of medical cannabis into Australia burgeoning industry. Now on to the show!